Showing results (1-10 of 568) with videos related to

Sort By:
Pageof 57
Clinical and Diagnostic Laboratory Immunology|November 5, 1998
Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control proceduresN Aziz, P Nishanian, J L Fahey
Cellular Immunology|April 1, 1995
Characterization of immune suppression by a synthetic HIV gp41 peptideH Wang, P Nishanian, J L Fahey
AIDS (London, England)|October 9, 1998
Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurementsJ L Fahey, J M Taylor, B Manna, et al.
The New England Journal of Medicine|January 18, 1990
The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1J L Fahey, J M Taylor, R Detels, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 24, 1998
Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onsetP Nishanian, J M Taylor, B Manna, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
Variables that affect assays for plasma cytokines and soluble activation markersN Aziz, P Nishanian, R Mitsuyasu, et al.
Clinical and Diagnostic Laboratory Immunology|July 17, 1998
Oral fluids as an alternative to serum for measurement of markers of immune activationP Nishanian, N Aziz, J Chung, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytesB Hofmann, P Nishanian, T Nguyen, et al.
Pageof 57